Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs
FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer
New Regimens May Benefit Multiple Myeloma Patients
Two New Modalities Promising For Relapsed/Refractory NHL
Amgen’s Kepivance Approved For Severe Oral Mucositis
Clolar Approved for Pediatric Refractory/Relapsed ALL
Blacks Half As Likely To Get Surgery For Esophageal Cancer
NCI-Approved Clinical Trials Listed For January
Trending Stories
- Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use
“Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”
- Cancer vaccine policy in limbo as CDC keeps canceling advisory meetings
